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Abstract
 
Herpes simplex virus (HSV) type 2 infection occurs primarily at the genital mucosal surfaces
and is a leading cause of ulcerative lesions. Despite the availability of animal models for HSV-2
infection, little is known regarding the mechanism of immune induction within the vaginal
mucosa. Here, we examined the cell types responsible for the initiation of protective Th1 immu-
nity to HSV-2. Intravaginal inoculation of HSV-2 led to a rapid recruitment of submucosal
dendritic cells (DCs) to the infected epithelium. Subsequently, CD11c
 
 
 
 DCs harboring viral
peptides in the context of MHC class II molecules emerged in the draining lymph nodes and
were found to be responsible for the stimulation of IFN
 
 
 
 secretion from HSV-specific CD4
 
 
 
T cells. Other antigen-presenting cells including B cells and macrophages did not present viral
peptides to T cells in the draining lymph nodes. Next, we assessed the relative contribution to
immune generation by the Langerhans cells in the vaginal epithelium, the submucosal CD11b
 
 
 
DCs, and the CD8
 
 
 
 
 
 lymph node DCs. Analysis of these DC populations from the draining
lymph nodes revealed that only the CD11b
 
 
 
 submucosal DCs, but not Langerhans cell–
derived or CD8
 
 
 
 
 
 DCs, presented viral antigens to CD4
 
 
 
 T cells and induced IFN
 
 
 
 secretion.
These results demonstrate a previously unanticipated role for submucosal DCs in the genera-
tion of protective Th1 immune responses to HSV-2 in the vaginal mucosa, and suggest their
importance in immunity to other sexually transmitted diseases.
Key words: genital mucosa • cytokines • lymph node • epithelium • sexually transmitted disease 
 
Introduction
 
The vaginal mucosa is under constant exposure to infec-
tious agents, and is consequently surveyed by a network of
 
dendritic cells (DCs).
 
*
 
 DCs are present in both the strati-
fied squamous epithelial layer as Langerhans cells (LCs) and
in the submucosal lamina propria in the vagina. Although a
similar population of the latter found in the skin, known as
the dermal DCs, has been shown to possess similar immuno-
stimulatory capacity to epidermal LCs in vitro (1, 2), vir-
tually nothing is known about the role of submucosal vagi-
nal DCs in the induction of mucosal immunity. Unlike
other mucosal tissues, the female reproductive tract un-
dergoes dramatic hormone-dependent changes over the
course of the menstrual cycle. Previous studies have shown
that mice are susceptible to intravaginal (ivag) herpes sim-
plex virus (HSV) type 2 infection only during the catabolic
metestrous-2 and the diestrous phases of the estrous cycle
(3–6). Thus, treatment of mice with progesterone (Depo-
 
Provera
 
®
 
), which maintains the mice at the diestrous-like
stage, is often required for consistent ivag infection with
HSV-2. However, the precise mechanism by which the
progesterone treatment increases the susceptibility to ivag
HSV-2 infection is unknown. One potential mechanism
relates to the thickness of the vaginal epithelial layer. With
the increase in serum estrogen levels, the epithelial cell
layer thickens during the estrous stage. Subsequently, with
the increase in the progesterone levels and decrease in the
estrogen, the superficial layers of the vaginal epithelium
are delaminated during metestrous phases and become
maximally thin by the diestrous stage. Another possible
mechanism for the increased susceptibility to HSV-2 ivag
infection in progesterone-dominant mice is the lack of an-
tigen-presenting cells (APCs) at the sites of infection re-
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*
 
Abbreviations used in this paper:
 
 a.i., after infection; APC, antigen-pre-
senting cell; DC, dendritic cell; HSV, herpes simplex virus; ivag, intra-
vaginal(ly); LC, Langerhans cell; TK, thymidine kinase. T
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quired to initiate immune responses, as frequency of LCs
may differ at each stage of the menstrual cycle within the
mouse vagina. Thus, it is important to determine the distri-
bution and function of DCs during the estrous cycle, as it
relates to the susceptibility of the female host to infectious
agents such as HSV-2.
A mouse model of ivag infection using HSV-2 thymi-
dine kinase (TK) mutant strain (6, 7) has provided impor-
tant insights into the mechanism of immune resistance to
HSV-2. The TK
 
  
 
mutant HSV-2 causes mild vaginal pa-
thologies that resolve within 7 d but do not result in neu-
rologic diseases, making it an ideal virus with which to
study immune induction to vaginal HSV-2 infection. Intra-
vaginal infection with TK
 
 
 
 HSV-2 is known to induce
protective immunity that is primarily mediated by IFN
 
 
 
-
secreted from CD4
 
 
 
 T cells (8, 9) and HSV-2–specific IgG
(10, 11). However, the viral infection events and APC
types involved in inducing the T cell responses to HSV-2
are poorly understood. A recent paper has demonstrated
that B cells represent the major cell type recruited from the
vaginal mucosa to the draining lymph nodes after ivag
HSV-2 delivery, suggesting a role for B cells in the im-
mune initiation process (12). In this paper, no migration of
LCs from the vagina to the draining lymph nodes was de-
tected, raising the question about whether LCs are in-
volved in antigen presentation and T cell activation in the
draining lymph nodes.
To understand the mechanism of immune induction by
DCs and other APCs to HSV-2 infection in the vaginal
mucosa, we examined the distribution, phenotype, and
function of DCs at the sites of infection and in the draining
lymph nodes. By following HSV-2 infection and DC dis-
tribution by immunofluorescence microscopy, we demon-
strate that HSV-2 productively infects the vaginal epithe-
lium exclusively and that submucosal DCs are recruited to
the lamina propria bordering the infected epithelium
within 24 h after infection (a.i.). In addition, we present
the time course of the appearance of DCs harboring HSV-2
peptides in the draining lymph nodes, the induction of
HSV-2–specific CD4
 
 
 
 T cell responses in the local drain-
ing lymph nodes and the subsequent migration of these
primed T cells to systemic lymphoid organs. Furthermore,
by isolating specifically the LCs and submucosal DCs from
the draining lymph nodes, we demonstrate that the primary
cells that migrate from the vaginal mucosa and present viral
antigens to CD4
 
 
 
 T cells are non-LC submucosal DCs.
The results from this paper provide the first evidence that
DCs are recruited rapidly to the lamina propria bordering
the infected vaginal epithelial cells infected with HSV-2,
and that these CD11c
 
 
 
/CD11b
 
 
 
 submucosal DCs, but not
LCs or CD8
 
 
 
 
 
 DCs, B cells, or other APCs, phagocytose
viral antigens and migrate to local lymph nodes to induce
protective Th1 CD4
 
 
 
 T cell responses.
 
Materials and Methods
 
Virus.
 
HSV-2 strains 186TK
 
 
 
Kpn were constructed as de-
scribed previously (13) and propagated and assayed on Vero cells
 
(14). All stocks were titered on the Vero cell line before use in
the ivag infections.
 
Animals and HSV-2 Infection. 
 
6–8-wk-old female BALB/c
mice were obtained from the National Cancer Institute. Mice
transgenic for TCR that recognizes OVA323–339 peptide in the
context of I-A
 
d
 
 (DO11.10TCR-
 
  
 
 transgenic mice) on a
BALB/c background were provided by Dr. Dennis Loh (Wash-
ington University, St. Louis, MO). The estrous stage of mice was
determined from analysis of vaginal smears taken by a calcium-
alginate swab (Fisher Scientific) and stained with Diff-Quik Stain
(Dade Behring) according to manufacturer’s instruction. Stained
cells were carefully examined and the estrous stage of each mouse
was identified as diestrous, estrous, metestrous-1, or metestrous-2
according to a previously established protocol (15, 16). For virus
infection studies, mice were injected subcutaneously in the neck
ruff with Depo-Provera
 
®
 
 (Pharmacia & Upjohn Diagnostics) at 2
mg/mouse in 100-
 
 
 
l volume 5–7 d before infection, swabbed
with calcium-alginate and inoculated ivag with either 10
 
7
 
 PFU of
HSV-2 strain 186TK
 
 
 
Kpn or inoculated with noninfected Vero
cell lysate (mock infection) in 10 
 
 
 
l volumes using a blunt-ended
micropipette tip. All procedures used in this paper complied with
federal guidelines and institutional policies by the Yale Animal
Care and Use Committee.
 
Antibodies.
 
The following antibodies were used for the iden-
tification of cell populations: anti-CD11c (N418), anti-CD11b
(M1/70), anti-CD8
 
 
 
 (53-6.7), anti-DEC205 (NLDC-145), and
anti–MHC class II (M5/114). The aforementioned antibodies
were purchased from BD Biosciences, except for NLDC-145 and
N418 which were purified from hybridoma supernatants. The
LC-specific anti-gp40 antibody G8.8 developed by Andrew Farr
(University of Washington, Seattle, WA), was obtained from the
Developmental Studies Hybridoma Bank developed under the
auspices of the National Institute of Child Health and Human
Development and maintained by the University of Iowa Depart-
ment of Biological Sciences. For localization of HSV-2–infected
cells, polyclonal rabbit antiserum against HSV-2 was purchased
from BioGenex.
 
Double Immunofluorescence Staining of Vaginal Tissues.
 
To ex-
amine the distribution of DC in relation to HSV-2 infection
within the vagina, frozen sections of vagina were stained with a
variety of antibodies in a procedure similar to that described previ-
ously (17) with minor modifications. In brief, 6–8-
 
 
 
m frozen sec-
tions were fixed in acetone and blocked with TNB buffer (3%
Casein in PBS; NEN Life Science Products) containing 5% nor-
mal donkey serum. To block endogenous biotin, the sections were
further treated with the Avidin–Biotin block (Vector Laborato-
ries), and endogenous peroxidase activity was quenched with 1%
H
 
2
 
O
 
2
 
. The primary antibody was applied at 5 
 
 
 
g/ml for 1.5 h at
room temperature. Slides were washed and incubated with biotin-
conjugated donkey F(ab
 
 
 
)
 
2
 
 anti–hamster IgG (Jackson Immu-
noResearch Laboratories, Inc.), followed by incubation with
streptavidin–HRP conjugate (Zymed Laboratories). The antigens
were detected using tyramide-FITC (NEN Life Science Products
Inc.) according to the manufacturer’s instructions. After the devel-
opment with the first antibody, sections were blocked with Avi-
din–Biotin, followed by incubation with 2% H
 
2
 
O
 
2
 
. The sections
were subsequently stained with the second primary antibody in a
similar manner as described above in the previous paragraph with
proper species-specific secondary antibody. The slides were devel-
oped with tyramide-tetramethylrhodamine (NEN Life Science
Products). At the end of the staining, slides were washed and incu-
bated with DAPI (Molecular Probes) and mounted with Fluoro-
mount-G (Southern Biotechnology Associates, Inc.). The stainedT
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slides were analyzed by fluorescence microscopy (Leitz Orthoplan
2) with a 20
 
 
 
 objective lens or by confocal microscopy using a
confocal laser microscope (model LSM510; Carl Zeiss MicroIm-
aging, Inc.) with a 20 or 40
 
 
 
 objective lens with water.
 
Preparation of Dendritic Cells and Other APCs.
 
DCs and other
APCs were prepared from draining lymph nodes of ivag HSV-2–
infected mice as described previously (18). In brief, draining
lymph nodes (inguinal and iliac), or in some cases spleen and me-
senteric lymph nodes, were excised from infected mice at various
time points. Lymph nodes were digested with collagenase D and
DNase I and incubated in the presence of 5 mM EDTA at 37
 
 
 
C
for 5 min. A single-cell suspension was prepared, and cells were
incubated with anti–mouse CD11c-coated magnetic beads
(Miltenyi Biotech) and selected on MACS separation columns
twice. Positively selected cells were routinely 80–90% DC based
on CD11c and MHC class II staining by flow cytometry. For
CD11c-depleted B cells and MHC class II
 
 
 
 cells, CD11c
 
 
 
 cells
were depleted from the draining lymph node suspension by label-
ing CD11c
 
 
 
 cells with the MACS separation beads (anti-
CD11c–coated beads) followed by selection using the LD deple-
tion column (Miltenyi Biotech). B220
 
 
 
 or I-A
 
d
 
 
 
 cells were
obtained from CD11c-depleted population by staining with
FITC-conjugated B220 or FITC-conjugated anti–MHC class II
antibody and selected on anti-FITC–conjugated MACS beads
according to the manufacturer’s instructions (Miltenyi Biotech).
The B220
 
 
 
- and I-A
 
d
 
 
 
–selected cells were routinely 80–90%
pure as determined by FACS
 
®
 
 (see Fig. 4 a). To prepare activated
DCs for experiments described in Fig. 3 e, transiently adherent
DCs were prepared from splenocytes of BALB/c mice as de-
scribed previously (19). For FACS
 
®
 
 sorting of LCs and submu-
cosal DCs, CD11c-enriched cells from the draining lymph nodes
were stained with anti-gp40 (rat IgG2a) followed by FITC-con-
jugated anti–rat Fab (Jackson ImmunoResearch Laboratories).
Cells were washed extensively and stained with anti-CD11b and
anti-CD11c. The submucosal DCs (CD11b
 
 
 
/gp40
 
 
 
/CD11c
 
 
 
)
and LCs (CD11c
 
 
 
/gp40
 
 
 
) were sorted to 99% purity. In separate
experiments, CD8
 
 
 
 
 
 and CD11b
 
 
 
 DCs were isolated from the
draining lymph nodes after staining of CD11c-enriched popula-
tion with antibodies to CD8
 
 
 
, CD11b, and CD11c. The CD8
 
 
 
 
 
DCs (CD8
 
 
 
 
 
/CD11c
 
 
 
/CD11b
 
 
 
) and CD11b
 
 
 
 DCs (CD11b
 
 
 
/
CD11c
 
 
 
/CD8
 
 
 
 
 
) were FACS
 
®
 
-sorted to 99% purity.
 
Isolation of CD4
 
 
 
 T Cells.
 
Draining lymph nodes (inguinal
and iliac) were excised from infected mice at the indicated time
points. Single-cell suspensions of lymph node cells were made by
dissociating cells through the cell strainer. Cells were washed
twice with PBS, stained with FITC-conjugated anti-CD4 anti-
body (eBioscience), and selected with magnetic beads conjugated
to anti-FITC antibody (Miltenyi Biotech) according to the
manufacturer’s instructions. Selected cells were checked by flow
cytometry and were routinely 90–95% pure CD4
 
 
 
 T cells. For
experiments involving ovalbumin-specific T cells (Fig. 3 f), in
vitro–activated CD4
 
 
 
 T cells were prepared by incubating total
splenocytes from DO11.10 mice in the presence of the ovalbumin
peptide (OVA323–339) for 72 h. CD4
 
 
 
 T cells were purified us-
ing MACS separation as described in the previous paragraph.
 
Stimulation of HSV-2–specific CD4
 
 
 
 T Cells by DCs and Other
APCs.
 
To determine the ability of the DCs to stimulate HSV-
2–specific T cells, 10
 
5
 
 CD4
 
 
 
 T cells from draining lymph nodes
of mice infected ivag with 186TK
 
 
 
Kpn 5 d before were co-cul-
tured with 10
 
5
 
 APCs in the presence of the heat-inactivated virus
or heat-inactivated nonvirus-infected cell lysate control. Virus-
infected (186TK
 
 
 
Kpn) or uninfected Vero cell control lysate was
heat-inactivated at 56
 
 
 
C for 30 min, at which point they were
 
determined noninfectious as assayed by addition to susceptible
Vero cells (unpublished data). No difference in proliferation or
cytokine secretion was detected between wells that received
heat-inactivated cell lysate and those that received media alone
(unpublished data). T cells were stimulated for 72 h in vitro by
various APCs and the supernatant was tested for cytokines by
ELISA as described previously (18). To determine the source of
cytokines in the co-culture, T cells or APCs, in some experi-
ments, were inactivated by irradiation at 3,000 rad.
 
Detection of Viral DNA in Purified DCs.
 
Total DNA from pu-
rified DCs or from infected vaginal epithelium was obtained by
resuspending the cell pellet in STE buffer (0.1 M NaCl, 10 mM
Tris-Cl, 1 mM EDTA, pH 8.0) and boiling for 10 min. HSV-2
glycoprotein B gene–specific primers HSV2a-1 (forward, 5
 
 
 
CTGGTCAGCTTTCGGTACGA 3
 
 
 
) and HSV2a-2 (reverse, 5
 
 
 
CAGGTCGTGCAGCTGGTTGC 3
 
 
 
) were used to amplify vi-
ral DNA as described previously (20). The presence of genomic
DNA was determined by PCR amplification of housekeeping
gene hypoxanthine-guanine phosphoribosyl transferase (HPRT)
using primers (forward, 5
 
 
 
CTGGAGGCAGGAAGGAGTCC
3
 
 
 
; reverse, 5
 
 
 
 GGTCCTCCTACGTTGTCTGG 3
 
 
 
) and ampli-
fying for 35 cycles. The lower limit of detection using our PCR
protocol was calculated by performing PCR on purified viral
DNA as follows. Cell-free 186TK
 
 
 
Kpn HSV-2 virions propa-
gated in Vero cells were collected from the culture supernatant
by centrifugation at 20,000 
 
g
 
 at 15
 
 
 
C (rotor SW27; Beckman
Coulter) for 45 min. The pellet containing cell-free virions was
collected, and viral genomic DNA was purified using QIAamp
DNA Mini Kit (QIAGEN). Eight 10-fold dilutions of DNA
were made, and 1 
 
 
 
l of each dilution was used as a template to
amplify viral DNA using the HSV2a-1 and HSV2a-2 primers as
described above in the previous paragraph. The lower limit of
detection by our PCR protocol was 30 viral particles per reac-
tion. Similarly, by isolating total DNA from in vitro–infected
Vero cells, our PCR protocol was able to consistently detect as
little as one infected cell per reaction.
 
Real-time PCR Analysis.
 
TaqMan Real-time PCR amplifica-
tion and detection were performed using a sequence detector
(model ABI 7700; PE Biosystems). HSV-2 TK gene-specific
primers (F145, 5
 
 
 
 CTGTTCTTTTATTGCCGTCATCG 3
 
 
 
and R263, 5
 
 
 
 GTCCATCGCCGAGTACGC 3
 
 
 
) and a fluores-
cence-labeled probe (5
 
 
 
 Fam-TTTGAACTAAACTCCCCCC-
ACCTCGC-Tamra 3
 
 
 
) were used to detect HSV-2 viral DNA.
Reactions were performed in 50-
 
 l volumes containing Taq-
Man Universal PCR Master Mix (PE Biosystems) with a final
concentration of 250 nM of each primer and 200 nM of Taq-
Man probe, and reactions were amplified for 40 cycles. 104 cell
equivalent amount of DNA samples extracted from draining
lymph node DCs were run in parallel with duplicated viral DNA
standards to determine the quantity of viral DNA molecules. For
viral DNA standards, purified HSV-2 viral DNA was serially di-
luted in the presence of 30 ng genomic DNA of uninfected
CV-1 cells. The viral DNA was diluted such that 1  l of the
sample contained 106, 105, 104, 103, 102, 10, and 100 of HSV-2
DNA. As little as two viral DNA copies could be routinely de-
tected in these assays.
Results
LC and DC Distribution in the Vaginal Mucosa during the
Estrous Cycle. To examine the distribution of DCs in the
uninfected vaginal epithelium and lamina propria duringT
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the estrous cycle, frozen sections of vagina from mice at
different stages of the estrous cycle were doubly stained
with antibodies to CD11c and MHC class II and analyzed
by confocal microscopy (Fig. 1). The epithelial cell thick-
ness was found to be minimal at diestrous (2–3 cells thick;
Fig. 1 a) and maximal at estrous (12 cells thick; Fig. 1 b).
During the catabolic metestrous-1 stage, the cornified vagi-
nal epithelium begins to shed (Fig. 1 c), and is replaced by
numerous neutrophils in the lumen with a few cell layers of
remaining epithelium at the metestrous-2 phase (Fig. 1 d).
Interestingly, the LCs (MHC class II  [red]/CD11c 
[green]; yellow) are distributed abundantly during the di-
estrous and metestrous-2 stages throughout the epithelial
layer, but only sparsely near the base of the epithelium dur-
ing estrous and metestrous-1 phases. Notably, there are no
LCs near the lumen of the vagina at these latter stages.
Thus, LCs localize near the lumen of the vagina only dur-
ing the catabolic phases in which the epithelium is maxi-
mally thin.
Submucosal DC Recruitment to the Infected Epithelium.
When mice at different stages of the estrous cycle were in-
fected with HSV-2, only those at diestrous and late
metestrous-2 phases or those that received Depo-Provera®
treatment became infected (unpublished data), which is
consistent with previous reports (3–6). In an effort to fol-
low the ivag HSV-2 infection and to understand the mech-
anism of immune induction to HSV-2, mice pretreated
with Depo-Provera® were infected ivag with 107 PFU of
the TK  strain of HSV-2 (186TK Kpn). Frozen sections
of the vagina of mice infected for 24 h, 48 h, or 5 d were
doubly labeled with antibodies to HSV-2 (red) and CD11c
(green) (Fig. 2). In the mock-infected mice, the epithelium
and lamina propria contained abundant CD11c  cells with
a similar frequency to those present in uninfected mice
(Fig. 2, a, c, e, and g). However, 24 h after ivag infection
with HSV-2, numerous CD11c  DCs were found in the
lamina propria just beneath the infected epithelium, creat-
ing multiple foci of submucosal DCs (Fig. 2 b). These sub-
mucosal DCs were all CD11b  as demonstrated for the
dermal DCs (21). A detailed analysis of the DCs near the
Figure 1. LC distribution in the vaginal epithelium during the estrous
cycle. Frozen sections of vaginal tissues from mice at diestrous (a), estrous
(b), metestrous-1 (c), and metestrous-2 (d) phases were stained with anti-
bodies against MHC class II (red) or CD11c (green) and analyzed by con-
focal microscopy. Confocal images are overlaid with light transmission
microscopy images to denote tissue morphology. The white line indicates
the luminal edge of the epithelium, whereas the yellow line indicates the
basement membrane. The images were captured using objective lenses of
20  (a–c) or 40  (d). L, lumen.
Figure 2. DC recruitment to the HSV-2–infected vaginal epithelium.
BALB/c mice pretreated with Depo-Provera® were inoculated with ivag
TK mutant HSV-2 (b, d, f, and h), or with control cell lysate (a, c, e, and
g), and vaginal tissues were collected for staining with antibodies against
CD11c (green) and HSV-2 (red) at 24 h (a, b, g, and h), 48 h (c and d), or
5 d (e and f) a.i. The nucleus was visualized by staining with DAPI (blue).
Images were captured using a 20  objective lens (a–f) or with 40x lens (g
and h). The epithelial layer is indicated by the white arrowheads (luminal
edge) and yellow arrowheads (basement membrane). Panels g and h rep-
resent higher magnification images of the selected areas in panels a and b,
respectively.T
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infected epithelium showed no evidence of direct infection
by HSV-2 (Fig. 2 h). By 48 h, the foci of DCs were re-
placed by a massive infiltration of DCs throughout the lam-
ina propria and the entire length of the epithelial layer was
now infected, which resulted in the shedding of the virally
infected, dying epithelia. By day 5, the vaginal tract was
devoid of most epithelial cells (Fig. 2 f) and virally infected
cells became rare. By days 7–10, the anatomy of the vaginal
mucosal returned to normal with the exception of the
appearance of clusters of lymphocytes near the lumen (un-
published data). Thus, successful HSV-2 replication oc-
curred exclusively in the epithelial cells in progesterone-
dominant mice; CD11c /CD11b  submucosal DCs were
recruited to the lamina propria just beneath the infected
epithelium as early as 24 h a.i.
Dendritic Cells Present HSV-2 Peptides in the Draining
Lymph Node. To understand the role of DCs in the im-
mune induction to HSV-2, we collected DCs in the drain-
ing lymph nodes at different time points after ivag infection
with 186TK Kpn. The draining lymph node cells were
positively selected on the basis of CD11c expression using
magnetic beads. The percentage of DCs expressing co-
stimulatory molecules CD80 and CD86 increased within
the first few days and returned to normal levels by 7 d a.i.
(Fig. 3 a). Next, the ability of the draining lymph node
DCs to present in vivo–derived viral antigens was exam-
ined by co-culture of CD4  T cells isolated from day 5
draining lymph nodes of HSV-2–infected mice in the ab-
sence of exogenously added antigens. The cytokine secre-
tion induced by DCs from HSV-2–specific CD4  T cells
was detected as early as 2 d a.i. and persisted for up to 10 d
a.i. (Fig. 3, b–d). Significant levels of IFN  were induced
by DCs draining the lymph nodes between 2 and 5 d a.i.
(Fig. 3 b). The same DCs stimulated much lower levels of
IL-10 (Fig. 3 c) and barely detectable levels of IL-4 (Fig. 3
d) from CD4  T cells. None of these cytokines were de-
tected from CD4  T cells isolated from mock-infected
mice stimulated under these conditions (unpublished data).
All cytokines (IFN , IL-4, and IL-10) were found to be se-
creted from CD4  T cells, but not DCs, because cytokine
levels diminished in the co-culture of irradiated CD4  T
cells with live DCs, but not in cultures of irradiated DCs
with live CD4  T cells (unpublished data).
Although cytokines were not detected from the CD4  T
cells in noninfected mice stimulated with DCs from in-
fected mice, it was possible that the cytokine secretion ob-
served in the DC–T cell co-culture in Fig. 3 (b–d) reflected
nonspecific stimulation of in vivo–primed T cells by the
activated DCs in the draining lymph nodes. To address
these possibilities, we performed two sets of experiments.
First, to determine whether the draining lymph node T
cells secreted cytokines in a nonantigen-specific manner,
CD4  T cells from mice infected for 4 d with HSV-2 were
co-cultured with in vitro–stimulated transiently adherent
splenic DCs. In the absence of viral antigen, even though
the transiently adherent overnight-stimulated DCs were
fully activated, they were not able to induce secretion of
cytokines from the draining lymph node CD4  T cells
(Fig. 3 e). Thus, the draining lymph node CD4  T cells re-
quire recognition of viral antigens for activation and secre-
tion of cytokines. Second, to determine whether the DCs
in the draining lymph nodes stimulated T cells nonspecifi-
cally, CD4  T cells from DO11.10 mice were preactivated
in vitro in the presence of OVA323–339 peptide. These
maximally activated clonal T cells were coincubated with
draining lymph node DCs from day 3 HSV-2–infected
mice in the presence or absence of the OVA peptide. Al-
though activated DO11.10 T cells secreted large amounts
of cytokines in the presence of the specific peptide, day 3
a.i. draining lymph node DCs were not able to induce cy-
tokine secretion in the absence of the antigenic peptide
(Fig. 3 f). Thus, cytokine secretion in the DC–T cell co-
culture requires the presence of specific viral antigens, and
Figure 3. DCs in the draining lymph nodes up-regulate co-stimulatory
molecules and present viral antigen. DCs were isolated from the draining
lymph nodes of mice inoculated ivag with HSV-2 or with control cell ly-
sate (mock) using magnetic beads. (a) Co-stimulatory molecules CD80
and CD86 expression levels were determined by flow cytometry. (b–d)
Cytokine secretion from HSV-2–specific CD4  T cells co-cultured with
draining lymph node DCs, or from CD4  T cells (day 5 a.i.) or DCs (day
3 a.i.) alone, were analyzed by ELISA. CD4  HSV-2–specific T cells
were obtained from the draining lymph node of day 5 ivag HSV-2–
infected mice by positive selection using magnetic selection. To demon-
strate the antigen specificity of the T cell responses, (e) DCs isolated from
the draining lymph nodes of either mock-infected or day 3 HSV-2–
infected mice, or in vitro–activated transiently adherent splenic DCs,
were coincubated with day 5 draining lymph node CD4  T cells in the
presence (filled) or absence (white) of exogenously added virus antigens. T
cell IFN  secretion was measured by ELISA. (f) To demonstrate the re-
quirement of specific antigen for T cell activation by the draining lymph
node DCs, in vitro–activated OVA-specific T cells were coincubated
with DCs isolated from the draining lymph nodes of either mock-infected
or day 4 HSV-2–infected mice in the presence (filled) or absence (white)
of OVA323–339 peptide. T cell IFN  secretion was measured by ELISA.T
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the mere activation status of the CD4  T cells, DCs, or
both in combination, does not account for the cytokines
observed in the co-culture.
Dendritic Cells Are the Primary APCs in IFN  Induction
from CD4  T Cells. In an effort to examine the relative
contribution of different APC populations in T cell prim-
ing during ivag HSV-2 infection, we isolated both the
CD11c  and CD11c  fractions of the draining lymph node
cells from mice infected ivag 5 d before. This time point
was chosen based on the ability of the draining lymph node
DCs between days 2 and 5 a.i. to optimally stimulate T
cells in vitro as shown in Fig. 3. The CD11c-depleted pop-
ulation was further divided into B220 /CD11c  and
I-Ad /CD11c  groups (Fig. 4 a). The two populations of
DCs (MHC class IImed vs. MHC class IIhi cells) were
present in the lymph nodes as described previously (22).
When HSV-2–specific CD4  T cells isolated from day 5
draining lymph nodes of HSV-2–infected mice were co-
cultured with these APC populations, remarkably, only T
cells stimulated with CD11c  DC population secreted high
levels of cytokines, whereas those stimulated with CD11c-
depleted lymph node APCs or with B cells had minimal
IFN  and IL-10 secretion (Fig. 4, b and c). The lack of T
cell stimulation by CD11c  APCs was not due to their in-
herent inability to present antigen on MHC class II mole-
cules because all APCs stimulated strong cytokine secretion
from HSV-2–specific T cells when exogenous viral anti-
gens were provided in vitro (Fig. 4, d and e). Together,
during HSV-2 infection, CD11c  DCs represent the pri-
mary APCs in stimulating IFN  secretion from viral anti-
gen-specific T cells in the draining lymph nodes.
Dendritic Cells Acquire HSV-2 Antigens in the Absence of
Direct Infection. The draining lymph node DCs could have
acquired the viral antigen either by phagocytosis of infected
epithelium or by direct HSV-2 infection. To our surprise,
no evidence of DC infection was detected by examination
of viral protein by immunofluorescence staining (Fig. 2) or
by detection of viral DNA by PCR (Fig. 5). The lower
limit of detection was 30 cell-free viral particles or one in-
fected Vero cell per reaction using our PCR protocol (Ma-
terials and Methods). To rule out the possibility of a very
low number of HSV-2 viral replication within DCs, a
more sensitive method of detection of viral DNA was used.
104 cell equivalents of total DNA from draining lymph
node DCs at days 1–3 a.i. were subjected to Real-time
PCR. Despite our ability to consistently detect as little as
two viral DNA copies per reaction, and that approximately
one million viral DNA copies were detected from vaginal
epithelial layers from the same mouse, none of the DNA
samples isolated from the draining lymph node DCs had
demonstrable viral DNA (Fig. 5 b). Moreover, no viral
DNA was detected from total lymph node cell suspension
(Fig. 5 b), indicating that viral replication is strictly con-
fined to the vaginal epithelial cells and that virus does not
travel to the draining lymph nodes.
Activation of CD4  T Cells in the Draining Lymph Nodes
and in the Spleen. To determine the time course of T cell
activation and migration in vivo, CD4  T cells were iso-
lated at various time points after ivag HSV-2 infection from
the draining lymph nodes and were incubated with irradi-
ated splenocytes from naive syngeneic mice pulsed with ei-
ther heat-inactivated virus or control lysate. After a 72-h
incubation in vitro, the supernatants were analyzed for se-
cretion of IFN , IL-4, and IL-10 (Fig. 6). Both IFN  and
IL-10 secretions were detected from T cells within the
draining lymph nodes starting at 3 d a.i. and persisted for
up to 14 d a.i. Only minor levels of IL-4 were secreted
from these cells. Thus, antigen-specific CD4  T cells be-
came detectable in the draining lymph nodes of ivag-
infected mice at 3 d a.i. and continued to be present until
14 d. In the spleen, HSV-2–specific T cell responses were
detected with a similar cytokine secretion profile to those
in the draining lymph nodes. However, the appearance of
HSV-2–specific T cells in the spleen began only after 5 d
a.i., which represents a 2-d lag from the draining lymph
node response, and disappeared by 14 d a.i. (Fig. 6).
Submucosal DCs Present Viral Peptides to CD4  T Cells in
the Draining Lymph Nodes. In an effort to delineate the
contribution of LCs and submucosal DCs in T cell priming
after HSV-2 infection, LC-derived DCs and submucosally
derived DCs in the draining lymph nodes were isolated by
flow cytometric cell sorting. LC-derived DCs were identi-
fied by staining with an antibody to gp40, a murine homo-
Figure 4. CD11c  DCs are crucial for IFN  secretion from HSV-2–
specific T cells. Various APC populations were isolated from draining
lymph nodes of day 5 infected mice by magnetic selection. CD11c  frac-
tion was obtained using the depletion column and was further subdivided
into B220  or I-Ad  groups by magnetic selection. (a) A representative
FACS® profile of these APC populations, gated on live cells, is shown.
These APC groups were used to stimulate HSV-2–specific CD4  T cells
in the absence (b and c) or presence (d and e) of exogenously added heat-
inactivated virus. Cytokines secreted from T cells were measured by
ELISA. The data are representative of three similar experiments. Each ex-
periment was conducted with three to four mice.T
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logue of the human epithelial cell adhesion molecule (23,
24). The gp40 molecule has been previously demonstrated
to be expressed specifically by LCs and not by other DCs
(23, 24). The submucosal CD11c  DCs were identified by
the expression of CD11b because CD11b is expressed on
all submucosal DCs as shown previously for dermal DCs
(21). First, we confirmed that the gp40 expression was only
detected in subcutaneous and vagina-draining lymph nodes
and was absent in nonskin-draining lymph nodes, such as
the mesenteric lymph nodes (Fig. 7 a). Second, phenotypic
analysis of the LC-derived gp40  DCs revealed that they
were DEC205hi, CD8 lo with moderate to high expression
of CD11b (Fig. 7 b), a profile completely consistent with
the phenotype of LCs in subcutaneous lymph nodes (25).
The FACS® analysis of LCs (gp40 ) and submucosal DCs
(CD11b /gp40 ) revealed that in the draining lymph
nodes, LC population diminishes whereas submucosal DCs
increase in percentage after HSV-2 infection (Fig. 7 b).
Strikingly, when the antigen-presenting capacity of these
DC populations were compared, only the CD11b  sub-
mucosal DCs, but not gp40  LCs, were found to present
viral antigens to CD4  T cells (Fig. 7 c), despite their equal
ability to present exogenously added viral antigens to
HSV-2–specific CD4  T cells (Fig. 7 d). Next, the ability
of the other major lymph node DC subset, namely the
CD8   DCs, to present viral antigens to CD4  T cells was
examined. The CD8   DCs have been shown to play a
critical role in cross-presentation of cell-associated antigens
(26–28). FACS® analysis of CD8   DCs revealed that they
also do not present HSV antigens to CD4  T cells in the
draining lymph nodes (Fig. 7, c and d). Together, these
data collectively show that submucosal DCs are recruited
to the infected epithelium, phagocytose exogenous viral
antigens, migrate to the draining lymph nodes, and are
uniquely capable of presenting viral antigenic peptides to
CD4  T cells.
Figure 5. Draining lymph node DCs do not contain HSV-2 viral
DNA. Total DNA was isolated from DCs from the draining lymph nodes
of mice inoculated ivag with HSV-2 or with control cell lysate using
magnetic beads. (a) HSV-2 viral DNA was amplified using specific prim-
ers by PCR. DNA isolated from 24 h HSV-2–infected vaginal epithelium
was used as a positive control for HSV-2–specific gene amplification. The
presence of genomic DNA in each sample is depicted by PCR amplifica-
tion of the housekeeping HPRT gene. To further confirm the lack of vi-
ral DNA in the DCs and total draining lymph node cells, either 104 (DCs)
or 105 (total lymph node cells) cell equivalents of DNA was subjected to
Real-time PCR at days 0, 1, 2, or 3 a.i. (b). In parallel, DNA obtained
from the vaginal epithelial layer (sites of viral replication) at the corre-
sponding time points were also examined by Real-time PCR as a positive
control for infection in these mice. These reactions were conducted twice
with similar results.
Figure 6. Cytokine secretion from CD4  T cells in draining lymph
nodes and spleen of ivag HSV-2–infected mice. CD4  T cells positively
selected from draining lymph nodes (a–c) and spleen (d–f) of mice in-
fected ivag with 186TK Kpn for various time periods were co-cultured
with irradiated syngeneic splenocytes in the presence of heat-inactivated
HSV-2 (filled bars) or heat-inactivated control cell lysate (white bars) for
3 d and supernatants were analyzed for IFN  (a and d), IL-10 (b and e),
or IL-4 (c and f).T
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Discussion
The mechanism of immune induction to ivag HSV-2 in-
fection is unclear. To better understand the contribution of
the vaginal APCs in immune induction to HSV-2, we first
examined the distribution of LCs and submucosal DCs in
the uninfected vaginal tissues at different stages of the es-
trous cycle. We demonstrate here that LCs are present dur-
ing estrous and metestrous-1 only near the base of the epi-
thelium. Because cornified epithelium covers the vaginal
mucosa during these stages of the estrous cycle, access by
infectious agents to deeper tissues is likely limited. Evolu-
tionarily, the localization of LCs near the mucosal surface
may not have been necessary during these particular stages
of the menstrual cycle when such a physical protective bar-
rier is provided. On the other hand, during the metestrous-2
and diestrous phases when the shedding of this barrier oc-
curs, the opportunity for sexually transmitted pathogens to
invade the host is greatly enhanced due to the lack of pro-
tective cornified epithelium and the reduced thickness of
the stratum spinosum. Consequently, a higher number of
LCs may have been necessary to survey invading microbes
at these stages. In the case of HSV-2 infection, mice are
found to be susceptible to viral infection only during these
catabolic stages (3–6).
The current paradigm of immune induction to infec-
tious agents at body surfaces covered by squamous epithe-
lium such as the skin and the vagina is that LCs encounter
pathogens within the epithelium, take up antigens from
the pathogens, and migrate to the draining lymph nodes to
prime naive T cells (29). In our current work, the rampant
HSV-2 infection of the vaginal epithelium resulted in the
complete lysis of the cells in this layer, destroying LCs in
this tissue within 48 h a.i. However, rapid recruitment of
submucosal CD11c  DCs just beneath the infected epithe-
lium was observed within 24 h a.i., followed by a subse-
quent appearance of CD11c /CD11b  DCs presenting
the viral peptides in the draining lymph nodes by 48 h a.i.
To decipher the relative roles of LCs and submucosal DCs
in antigen presentation and T cell activation in the drain-
ing lymph nodes, LCs and submucosal DCs were isolated
by FACS® from draining lymph nodes after HSV-2 infec-
tion. Stimulation of HSV-2–specific T cells revealed that
only the submucosal DCs, and not LCs, presented viral an-
tigens to CD4  T cells (Fig. 7). Our observations that sub-
mucosal DCs, but not LCs, are the primary cells responsi-
ble for T cell priming in the draining lymph nodes after
ivag HSV-2 infection are also supported in a paper by Parr
et al., which tracked the emigrant cells from vaginal epi-
thelium with a fluorescent dye (12). With this method, no
migration of the LCs from the vaginal epithelium to the
draining iliac lymph nodes was observed after ivag HSV-2
infection (12). Furthermore, we examined the antigen-
presenting capacity of the CD8   lymph node DCs that
have been shown to be responsible for presenting cell-
associated antigens to T cells in vivo (26–28). Comparison
of the ability of the two major subsets of DCs in the drain-
ing lymph nodes clearly demonstrates that only the
CD11b  DCs, but not CD8   DCs, present in vivo–
derived viral peptides to CD4  T cells (Fig. 7, c and d).
These results indicate that the viral antigens are presented
directly by the CD11b  DCs in the absence of either anti-
gen transfer to the lymph node CD8   DC or the differ-
entiation of these cells to the CD8   phenotype. To-
gether, our data demonstrate a previously unrevealed role
of the submucosal DCs in antigen presentation to CD4  T
cell after ivag HSV-2 infection, and further provide evi-
dence for the lack of participation by LCs and the CD8  
DCs in this process.
Figure 7. Submucosal DCs, but not Langerhans cells or CD8   DCs,
present viral peptides to CD4  T cells in the draining lymph nodes. To
differentiate the contribution of LCs and submucosal DCs in the presen-
tation of HSV-2 antigens in vivo, CD11c  cells were stained with gp40
(LC) and CD11b (submucosal DC) after HSV-2 ivag infection at 2 or 4 d
a.i. and were analyzed by flow cytometry (a). The DC markers, DEC-205,
CD8 , and CD11b, on CD11c  cells were analyzed (b). The LC-derived
(gp40 ), submucosal DCs (CD11b ), or the CD8   DCs were FACS®-
sorted from draining lymph nodes at 2 or 4 d a.i. and were co-cultured
with HSV-2–specific CD4  T cells in the absence (c) or presence (d) of
viral antigens for 72 h. IFN  secreted from T cells were analyzed by
ELISA (c and d).T
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Several studies have examined the consequences of di-
rect infection of DCs by HSV-1 in vitro. Human DCs
have been shown to express some of the receptors required
to mediate the entry of HSV such as Hve-A and Hve-B
and can be infected by HSV-1 in vitro (30, 31). HSV-1 in-
fection was shown to inhibit maturation of immature DCs
(30, 31) and their ability to prime naive T cells (31). Our in
vivo examination with TK  HSV-2 revealed that the in-
fection was not detected within the emigrant DC popula-
tions in the draining lymph nodes, despite the proximity of
recruited submucosal DCs to the infected epithelium. In
fact, the draining lymph nodes did not contain any viral
DNA. Our finding is consistent with the paper by Mueller
et al., which demonstrates that despite rapid activation of
CD8  T cells after footpad HSV-1 infection, the draining
lymph nodes contained no viral DNA (32). The difference
in the infectivity of human blood DCs to HSV-1 in vitro
and mouse genital submucosal DCs to HSV-2 in vivo may
be explained by a number of factors, including the differ-
ence in expression of Hves (unpublished data) and the fact
that murine Hve-B does not function as a viral entry medi-
ator for HSV (33). Productive replication of HSV-2 was
strictly confined to the epithelial layer, within which LCs
reside. Thus, our data suggest that LCs may be inhibited
from performing antigen-presenting functions as a result of
the lytic destruction of the epithelial layer. This hypothesis
is supported by the progressive reduction of the number of
LCs in draining lymph nodes after HSV-2 infection (Fig. 7
a). Conversely, we show that HSV-2 infection of the epi-
thelium did not lead to suppression, but instead to activa-
tion of the phenotype and function of the neighboring un-
infected submucosal DCs. The factors released by the
HSV-infected epithelial cells, or the virus itself, are likely
responsible for inducing activation of the submucosal DCs.
A clear picture of immune inductive events after ivag
HSV-2 infection emerges from our work. Upon entry into
vaginal lumen, HSV-2 specifically infects the diestrous
vaginal epithelium. This infection event results in the re-
cruitment of submucosal DCs toward the infected epithe-
lium, presumably from both local lamina propria and pe-
ripheral sources. After recruitment, the foci of DCs
directly beneath the infected epithelium form within 24 h
and DCs continue to accumulate for several days. This
event in the vaginal mucosa is accompanied by the appear-
ance of DCs that harbor HSV-2 peptide on their cell sur-
face MHC class II capable of stimulating HSV-2–specific T
cells in the draining lymph nodes. The DCs that migrate to
the draining lymph nodes during the first 2–3 d a.i. express
higher levels of costimulatory molecules, and are thus ca-
pable of stimulating antigen-specific T cells. Lagging 1 d
behind, CD4  T cells capable of secreting high levels of
IFN  and moderate levels of IL-10 in an HSV-2–specific
manner begin to become detectable in the draining lymph
nodes first, and subsequently in the spleen. The HSV-2–
specific Th1 cells found in the spleen likely migrated from
the priming lymph nodes because we detected no evidence
of antigen-presenting DCs in the spleen or in any other
nondraining lymph nodes at any time points examined. To
our surprise, despite the fact that numerous CD4  T cells
were present in the draining lymph nodes at 14 d a.i., we
did not detect cytokine secretion from CD4  T cells by
this time point. Furthermore, HSV-2–specific CD4  T
cells were not found in the spleen at this time. It is possible
that regulatory T cells develop in these tissues that prohibit
secretion of cytokines from effector Th1 cells. Alterna-
tively, the HSV-2–specific effector memory T cells may
have migrated to nonlymphoid tissues as described for
lymphocytic choriomeningitis virus (34). In support of the
latter possibility, despite our inability to detect effector T
cells in the lymphoid tissues after 14 d a.i., these cells are
clearly present and are recruited rapidly to the sites of in-
fection and mediate protective immunity during secondary
viral challenges (8, 9).
Our data provide the first evidence of the critical role
played by the submucosal vaginal DCs in eliciting IFN -
mediated CD4  T cell responses during ivag HSV-2 infec-
tion. Because the expression of receptors and adhesion mol-
ecules for various sexually transmitted pathogens may differ
significantly between the submucosal DCs and LCs of the
vaginal mucosa (35), our results suggest the importance of
the involvement of the submucosal vaginal DC populations
in disease pathogenesis and in immune induction to other
microbial agents of sexually transmitted diseases.
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